Connect Biopharma Holdings Ltd (CNTB)

Nov 03, 2025

Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3 - Bucyrus Telegraph-Forum

Nov 03, 2025

Oct 31, 2025

This Immuneering Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Oct 31, 2025

Oct 31, 2025

Connect Biopharma stock initiated with Buy rating at BTIG on respiratory drug potential - Investing.com Nigeria

Oct 31, 2025

Oct 31, 2025

BTIG Initiates Coverage on Connect Biopharma Hldgs (CNTB) with 'Buy' Rating | CNTB Stock News - GuruFocus

Oct 31, 2025

Oct 29, 2025

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Short Interest Update - MarketBeat

Oct 29, 2025

Oct 29, 2025

Connect Biopharma (NASDAQ:CNTB) Stock Price Down 3.8%What's Next? - MarketBeat

Oct 29, 2025

Oct 27, 2025

All In Solutions Detox Enhances California Center Recovery Environment Through Tranquil Setting - The News Journal

Oct 27, 2025

Oct 27, 2025

RestoPros of Southwest Florida Expands Damage Restoration Services Across Multiple Counties - azcentral.com and The Arizona Republic

Oct 27, 2025

Oct 25, 2025

Connect Biopharma's (CNTB) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat

Oct 25, 2025

Oct 19, 2025

Hyperke Growth Partners Reveals How They Help SEO Agencies with Qualified Lead Generation in Case Study - azcentral.com and The Arizona Republic

Oct 19, 2025

Oct 10, 2025

Connect Biopharma's (CNTB) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 10, 2025

Oct 08, 2025

Severe Asthma Pipeline 2025: Therapies Under Investigation, - openPR.com

Oct 08, 2025

Oct 07, 2025

Connect Biopharma (NASDAQ:CNTB) Stock Price Up 7.4%Still a Buy? - MarketBeat

Oct 07, 2025

Oct 07, 2025

Connect Biopharma Holdings Limited (CNTB) stock price, news, quote and history - Yahoo

Oct 07, 2025

Oct 06, 2025

October 2025's Promising Penny Stocks To Consider - Yahoo Finance

Oct 06, 2025

Oct 03, 2025

Short Interest in Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Drops By 53.6% - MarketBeat

Oct 03, 2025

Sep 30, 2025

H.C. Wainwright reiterates Buy rating on Connect Biopharma stock at $7 target By Investing.com - Investing.com South Africa

Sep 30, 2025

Sep 30, 2025

H.C. Wainwright reiterates Buy rating on Connect Biopharma stock at $7 target - Investing.com Nigeria

Sep 30, 2025

Sep 29, 2025

507mL Lung Function Improvement: Connect Bio's New Asthma Drug Shows Remarkable Results in High-Risk Patients - Stock Titan

Sep 29, 2025

Sep 26, 2025

James Huang to join CASI Pharmaceuticals board as independent director By Investing.com - Investing.com Australia

Sep 26, 2025

Sep 26, 2025

CASI Pharmaceuticals Appoints James Huang to Board of Directors - ACCESS Newswire

Sep 26, 2025

Sep 26, 2025

35-Year Biotech Veteran James Huang Joins CASI Pharma Board as Company Advances CID-103 Program - Stock Titan

Sep 26, 2025

Sep 22, 2025

Eosinophilic Asthma Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Lanier Biotherapeutics, Bio-Thera Solutions, Kinaset Therapeutics, CSPC ZhongQi Pharma - Barchart.com

Sep 22, 2025

Sep 22, 2025

Eosinophilic Asthma Pipeline 2025: Therapies, MOA Insights, - openPR.com

Sep 22, 2025

Sep 20, 2025

FY2025 EPS Estimate for Connect Biopharma Lowered by Analyst - MarketBeat

Sep 20, 2025

Sep 18, 2025

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Sees Large Drop in Short Interest - MarketBeat

Sep 18, 2025

Sep 09, 2025

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Short Interest Up 204.8% in August - MarketBeat

Sep 09, 2025

Sep 08, 2025

Asthma Market to Show Paltry Growth at a CAGR of 1.95% During the Forecast Period (2025-2034) | DelveInsight - Yahoo Finance

Sep 08, 2025

Sep 06, 2025

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Sees Large Increase in Short Interest - Defense World

Sep 06, 2025

Sep 04, 2025

Connect Biopharma Announces Poster Presentations of Rademikibart at the European Respiratory Society Congress 2025 - Quiver Quantitative

Sep 04, 2025

Sep 04, 2025

New Asthma Treatment Data: Connect Biopharma's Rademikibart Shows Impact on FEV1 in Type 2 Asthma Trial - Stock Titan

Sep 04, 2025

Sep 03, 2025

Connect Biopharma completes termination of its American depositary receipt program and directly lists its ordinary shares on Nasdaq - MarketScreener

Sep 03, 2025

Sep 03, 2025

Connect Biopharma Ends ADR Program, Moves to Direct Nasdaq Listing; Shares Up Premarket - MarketScreener

Sep 03, 2025

Sep 03, 2025

Connect Biopharma Completes Termination of its American - GlobeNewswire

Sep 03, 2025

Sep 03, 2025

Biotech Connect Biopharma Completes Strategic Shift to Direct Nasdaq Listing for U.S. Growth - Stock Titan

Sep 03, 2025

Sep 02, 2025

COPD Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma - Barchart.com

Sep 02, 2025

Sep 02, 2025

3 Penny Stocks To Watch With Market Caps Over $100M - simplywall.st

Sep 02, 2025

Aug 29, 2025

Connect Biopharma (CNTB) Expected to Announce Quarterly Earnings on Friday - Defense World

Aug 29, 2025

Aug 27, 2025

Connect Biopharma Holdings Limited to Participate in Upcoming Healthcare Conferences - Quiver Quantitative

Aug 27, 2025

Aug 27, 2025

Clinical-Stage Biotech Connect Biopharma Announces Key September Investor Conference Appearances - Stock Titan

Aug 27, 2025